PRINCE-1: safety and efficacy of atazanavir powder and ritonavir liquid in HIV-1-infected antiretroviral-naïve and -experienced infants and children aged ≥3 months to <6 years

por Strehlau, Renate, Donati, Anamaria Pena, Arce, Pedro Martinez, Lissens, Jurgen, Yang, Rong, Biguenet, Sophie, Cambilargiu, Daniela, Hardy, Hélène, Correll, Todd
Publicado 2015

Effect of clopidogrel discontinuation at 1 year after drug eluting stent placement on soluble CD40L, P-selectin and C-reactive protein levels: DECADES (Discontinuation Effect of Cl...

por Wykrzykowska, Joanna J., Warnholtz, Ascan, de Jaeger, Peter, Curzen, Nick, Oldroyd, Keith G., Collet, Jean Philippe, Ten Berg, Jurrien M., Rademaker, Tessa, Goedhart, Dick, Lissens, Jurgen, Kint, Peter-Paul, Serruys, Patrick W.
Publicado 2009